STONE HOUSE BREWERY LIMITED
Company number 07131024 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: Stone House Brewery Limited
1. Financial Health Score: C+ The patient is suffering from a chronic liquidity condition (negative working capital) but is kept alive by the life support of directors' loans and solid fixed assets. While underlying profitability is showing signs of improvement, the business is highly vulnerable to sudden cash flow shocks. The immune system (cash reserves) is weak, making the company susceptible to external economic infections.
2. Key Vital Signs
- Blood Pressure (Liquidity Ratio): Dangerously Low Current Assets (£133,202) vs. Current Liabilities (£227,015) yields a Current Ratio of just 0.58:1. A healthy business typically maintains a ratio above 1.5:1. The company cannot cover its short-term debts using its short-term assets, indicating severe cash flow anemia.
- Pulse (Cash Health): Weak but Steady Cash at bank stands at £35,105. While this is a slight improvement from the £27,160 seen in 2022, it remains notably lower than pre-pandemic levels (£62,133 in 2016). The pulse is present, but it is faint.
- Metabolism (Profitability): Recovering The Profit and Loss reserve grew from £74,006 in 2024 to £100,856 in 2025, indicating a retained profit of £26,850 for the year. This is a positive sign—the business metabolism is generating energy (profit) once again after a period of decline that saw shareholders' funds drop from £272,488 in 2016 to a low of £75,900 in 2024.
- Cholesterol (Debt Burden): High Total liabilities stand at £227,015 (current) + £146,232 (long-term) = £373,247 against total assets of £579,927. The company is highly leveraged, with a significant portion of its "cholesterol" consisting of HMRC debts (VAT owed: £68,279) and finance leases.
- Bone Density (Fixed Assets): Strong The company owns £304,368 worth of freehold land and property. This provides a solid structural foundation and represents the primary store of value within the business, preventing the overall financial health score from dropping lower.
3. Diagnosis
The financial data reveals a business experiencing acute working capital deficiency. The patient is asset-rich but cash-poor.
The most alarming symptom is the negative working capital of (£93,813). The business is currently funding its day-to-day operations by stretching its creditors—particularly HMRC (VAT) and trade suppliers—rather than through organic cash generation. This is a classic symptom of distress in the brewing and manufacturing sector, where stock (£57,760) and debtors (£40,337) tie up vital cash.
Furthermore, the directors are providing essential financial life support. Directors' loan accounts due within one year have surged from £28,600 to £49,810. Without this internal transfusion of cash, the business would likely face severe insolvency risks.
However, the prognosis is not entirely grim. The underlying metabolism is healing; the return to profitability in 2025 and the steady increase in employee headcount (from 29 to 31) suggest that the core brewing operations are viable and growing. The issue lies not in the product, but in the financial structure supporting it.
4. Recommendations
To restore full financial wellness, the following prescriptions are recommended:
- Financial Surgery (Refinancing): The freehold property (£304,368) represents untapped equity. The directors should urgently consider refinancing the property via a long-term commercial mortgage to clear the short-term directors' loans, HMRC VAT debt, and trade creditors. This would swap toxic short-term debt for manageable long-term debt and instantly cure the working capital deficiency.
- Diet and Exercise (Working Capital Management): Implement stricter inventory and debtor management. With £57k tied up in stock and £40k in debtors, accelerating the cash conversion cycle is vital. Chase outstanding invoices aggressively and consider just-in-time stock purchasing to free up vital cash flow.
- Vitamin Supplements (Directors' Loan Formalisation): The increasing reliance on directors' loans is unsustainable. If the loans are converted to equity, it will strengthen the balance sheet and reduce the anxiety of sudden repayment demands that could push the company into administration.
- Regular Check-ups (Cash Flow Forecasting): The business must implement rigorous 13-week rolling cash flow forecasts. Given the tight cash position, even a minor unexpected expense could cause a cardiac arrest. Forecasting will ensure there are no surprises.